Dossier
head and neck squamous cell carcinoma
Coverage of head and neck squamous cell carcinoma in the Nexus archive.
- Ultra-low doses could bring costly cancer treatments to more patients in poorer countries
A lower-cost immunotherapy approach using ultra-low doses may extend survival for patients with advanced head and neck squamous cell carcinoma in resource-limited countries, according to research presented at the American Society of Clinical Oncology annual meeting.